HEC96719, CAS [[2181834-03-5]]

Produktübersicht

• Artikelname: HEC96719, CAS [[2181834-03-5]]
• Artikelnummer: MCE-HY-153114
• Hersteller Artikelnummer: HY-153114
• Alternativnummer: MCE-HY-153114-10MG,MCE-HY-153114-100MG,MCE-HY-153114-5MG,MCE-HY-153114-10MMX1ML,MCE-HY-153114-50MG,MCE-HY-153114-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

HEC96719 is a selective and orally active tricyclic farnesoid X receptor (FXR) agonist with EC50 values of 1.37 and 1.55 nM by time-resolved fluorescence energy transfer (TR-FRET) and luciferase reporter assays, respectively. HEC96719 significantly improves non-alcoholic steatohepatitis (NASH) and liver fibrosis with favorable tissue distribution in liver and intestine. HEC96719 can be used for the research of non-alcoholic steatohepatitis[1].

Produkteigenschaften

• Molekulargewicht: 549.40
• Reinheit: 98.01
• CAS Nummer: [2181834-03-5]
• Formel: C29H22Cl2N2O5
• Target-Kategorie: FXR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1